Pasteur’s Quadrant: a wonderful example of KISS*?
Our scientists are all doing great work in diverse areas, how could I define this work to ensure it was creating value for the company? Stokes model of the Pasteur's Quadrant provided the inspiration I needed, says Dr...
Read more
Learning from the past: portfolio management in pharma R&D
Pharmaceutical R&D is a complex, long and expensive task with a high project attrition rate. Only 5% of drug projects, that reach the stage of first human dose progress through all phases of clinical trials to reach patients.
Read more
Portfolio Visualisation: Making it easy, being transparent, making better decisions
A good understanding of the R&D pipeline and portfolio is essential to reduce waste, duplication and poor use of valuable resources, says Joe de Sousa of AstraZeneca
Read more
R&D Management Conference
A highlight of the year is the R&D Management Conference. The 2016 conference 'From Science to Society: Innovation and Value Creation' was held in Cambridge, UK, and the 2017 conference will be held at the University of Leuven, Belgium,...
Read more
R&D Management Conference highlights for practitioners
R&D Management Conference includes many sessions of interest to practitioners including keynotes by Warren East of Rolls-Royce plc, Joe de Sousa AstraZeneca, David Teece Haas School of Business and Mark Samuels NIHR.
Read more
